# Study of the Safety and Effectiveness of HIFU Combined With REGOTORI for Metastatic Colorectal Cancer

> **NCT04819516** · PHASE1 · UNKNOWN · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 10 (estimated)

## Conditions studied

- Colorectal Cancer

## Interventions

- **PROCEDURE:** high-intensity focused ultrasound therapy
- **DRUG:** Toripalimab

## Key facts

- **NCT ID:** NCT04819516
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12-07
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2021-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04819516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04819516, "Study of the Safety and Effectiveness of HIFU Combined With REGOTORI for Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04819516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*